Cysteinyl leukotrienes are key mediators of inflammatory responses and immediate hypersensitivity reactions [1, 2] . They are generated from arachidonic acid and glutathione in activated cells of myeloid origin by reactions catalyzed by 5-lipoxygenase (5-LO) and leukotriene C 4 synthase (LTC 4 S). 5-Lipoxygenase activating protein (FLAP) is structurally related to LTC 4 S and facilitates the transfer of arachidonic acid released from membrane phospholipids to 5-LO [3] . Ca 2+ activates the 5-LO [3] and causes it to translocate from cytosol and nuclear matrix to the nuclear envelope [4] where it forms the unstable epoxide leukotriene (LT)A 4 . Addition of glutathione to LTA 4 is catalyzed by LTC 4 S [5, 6] . MK886 1 prevents 5-LO translocation to the nuclear envelope and inhibits LT-biosynthesis in cells [7] by its tight binding to the 18 kDa membrane protein FLAP [8] . In addition to its function as an arachidonic acid carrier for 5-LO [3, 9] FLAP has been postulated to serve as an anchor for 5-LO at the nuclear envelope following cell activation. It is likely that interactions at the nuclear envelope between components of the leukotriene biosynthetic complex are crucial for the control of leukotriene synthesis. LTC 4 S has previously been shown to form homo-oligomers in living cells [10] but also to interact with FLAP [11] and microsomal glutathione S-transferase 1 (MGST1) [12] . The crystal structures of MGST1, LTC 4 S and FLAP have shown strong similarities including homotrimeric structures for all three proteins [13] [14] [15] [16] . and SDS-PAGE molecular weight standard (broad range) from BioRad (Hercules, CA). All other materials were from sources described before [17] .
Materials and Methods

Materials
Recombinant plasmids. Human 5-LO cDNA, cloned into the EGFP fusion protein vector (pEGFP-h5-LO), was a kind gift from Dr T. Izumi, Gunma University, Japan. Human FLAP cDNA cloned into a pcDNA3 expression vector was kindly provided by Dr T. Bigby, UCSD (San Diego, CA) and human 5-LO cDNA cloned into a pUC13 vector was kindly provided by Dr M.
Abramovitz, Merck Frosst (Canada). Preparation of pRluc-hLTC 4 S and pGFP-hLTC 4 S (full length and truncated forms) has been described previously [10, 18] . Full length and truncated forms of LTC 4 S were excised from the pGFP vector and subcloned in frame with GST in a pGEX vector. Full length LTC 4 S was also subcloned into a pDsRed vector and full length human 5-LO cDNA was subcloned into pGEX and pcDNA3. Human full length FLAP cDNA was amplified by PCR and subcloned into pGFP 2 -C2 and pGEX vectors. Three truncated forms of FLAP cDNA encoding amino acids 1-51, 47-119 and 107-161 were amplified by PCR (Table I ) and subcloned into pGEX for production of GST fusion proteins.
GST pull-down assays.
35 S-Methionine-labeled 5-LO and FLAP were prepared using TNT® kit and pcDNA3-h5-LO or pcDNA3-hFLAP. GST fusion proteins were isolated from 500 ml cultures of E.coli Y1090 transformed with pGEX, pGEX-LTC 4 S (or its truncated forms), pGEX-5-LO or, pGEX-FLAP (or its truncated forms). The GST proteins were immobilized on GSH-Sepharose beads and diluted in NET-N buffer (50mM Tris-HCL pH 7.4, 150 mM NaCl,
Gene sequence
Forward primer Reverse primer penicillin (100 U/ml) and streptomycin (100 μg/ml) and split 1:5 at confluence.
Transient transfection. HEK-293/T cells and COS-7 were transfected using polyethyleneimide as previously described [17, 18] .
Fluorescence microscopy. HEK-293/T and COS-7 cells transfected with fluorescent fusion proteins were analyzed by fluorescence microscopy as previously described [18] . Some cells were incubated at 37 o C with 10 μM calcium ionophore A23187 for 20 min before fixing. pGFP fusion constructs or pGFP, were analyzed for protein-protein interaction by BRET as described [10, 18] . In some experiments, cells were incubated in serum-free medium with 10 µM 
Results
Interaction analyses by GST pull-down technique
GST pull-down experiments were performed using GST-fusion proteins of full length 
Confocal fluorescence microscopy
HEK-293/T cells, co-transfected with GFP-FLAP or GFP-LTC 4 S and dsRed-ER, showed
clear co-localization of these proteins at the nuclear envelope and endoplasmatic reciculum (Fig   2, left top) . Similar distributions were seen using COS-7 cells co-transfected with GFP-FLAP or GFP-LTC 4 S and DsRed-ER (Fig. 2, right top) . In another experiment COS-7 cells were cotransfected with GFP-FLAP and DsRed-LTC 4 S (Fig. 2, bottom) . Taken together the results showed that FLAP and LTC 4 S co-localized not only with the endoplasmic reticulum marker but also with one another even though small areas were seen with LTC 4 S without FLAP (Fig. 2, bottom). (Fig. 1A:2) .
D. FLAP interacts with 5-LO: Truncation of GST-FLAP affected [
35 S] 5-LO binding less than that seen for LTC 4 S truncation mutants in Fig. 1 A-B. 
E. LTC 4 reduces 5-LO interaction with FLAP:
The interaction between GST-5-LO and [
35 S] FLAP was not affected by the FLAP inhibitor MK886 but was diminished by LTC 4 . F. Depiction of hydrophilic (white) and hydrophobic (black) domains of LTC 4 S and FLAP. HEK293/T or COS-7 cells transfected with GFP-5-LO expressed most of the fluorescent fusion protein within the nuclear matrix and cytosol in non-stimulated cells (Fig. 3, row 1 ). After stimulation with A23187 a clear translocation of fluorescence to the nuclear envelope was observed (Fig. 3, rows 2-3) . In stimulated HEK293/T and COS-7 cells the activated 5-LO appeared mainly at the nuclear envelope and partly co-localized with the ER-marker, previously shown to co-localize with LTC 4 S and FLAP. 4 S co-localize. HEK293/T and COS-7 cells were co-transfected with GFP-FLAP or GFP-LTC 4 S and pDsRed-ER or pDsRed-LTC 4 S constructs. FLAP and LTC 4 S co-localized with each other and with the ER marker at the nuclear envelope.
Fig. 2 FLAP and LTC
BRET -oligomerization assay in living cells
5-LO, and LTC 4 S were tested for interaction in living cells using BRET assay. Cells coexpressing Rluc-LTC 4 S and GFP-LTC 4 S gave high BRET ratios (Fig. 4A) indicating that homooligomer formation took place as we have reported before [10] . Rluc-LTC 4 S and GFP-5-LO gave very low BRET ratios in non-stimulated cells. However, when the cells were treated with A23187, the BRET ratio increased substantially, indicating that 5-LO and LTC 4 S interact physically in activated cells (Fig. 4B ). As shown above ionophore stimulation caused GFP-5-LO to translocate to the nuclear envelope thus permitting its interaction with LTC 4 S which is localized there. Western blot analyses of cells from BRET experiment showed that the expression of GFP and 5-LO protein did not vary and excluded that different transfection efficiencies had influenced the BRET analyses (data not shown).
Fig. 3
5-LO translocates from nuclear matrix and cytosol to the nuclear envelope. HEK293/T and COS-7 cells were co-transfected with GFP-5-LO and pDsRed-ER. Upon activation with calcium ionophore A23187, 5-LO translocated to the nuclear envelope as shown by partial co-localization with the ER-marker. COS-7 cells were transfected with GFP 5-LO and treated with A23187 and ToPro3 nuclear stain. GFP-5-LO translocated to the nuclear envelope upon ionophore activation.
Discussion
We report here that FLAP and LTC 4 S were co-localized at the ER and nuclear envelope in Both hydrophilic loops of LTC 4 S and FLAP point to the ER luminal side [19] suggesting that 5-LO is translocated to this side of the ER / nuclear envelope upon cell activation, a notion which is supported by our BRET experiments. 4 S interact in activated cells. Bioluminescence resonance energy transfer (BRET) assays were performed as previously described [10, 18] . Data are expressed as mean values ± standard deviation (n=3). For further details, see Materials and Methods. Panel A: homooligomerization of LTC 4 S occurred as previously reported [10] . Panel B: Results indicate that 5-LO and LTC 4 S interact in ionophore-stimulated but not in un-stimulated cells.
Fig. 4 5-LO and LTC
